Free Trial
→ Are we ignoring the same signal Wall Street ignored in 1929? (From Weiss Ratings) (Ad)tc pixel Free INZY Stock Alerts

This company has been marked as potentially delisted and may not be actively trading.

Inozyme Pharma (INZY) Short Interest Ratio & Short Volume

Inozyme Pharma logo
Compare

Inozyme Pharma Short Interest Overview

As of June 15, 2025, Inozyme Pharma (INZY) had a short interest of 3.38 million shares sold short, representing 7.79% of the public float. This marks a -8.15% decrease in short interest since the prior report. The short interest ratio (days to cover) is 1.6, meaning it would take 1.6 days of the average trading volume of 2.79 million shares to cover all short positions.

Current Short Interest
3,380,000 shares
Previous Short Interest
3,680,000 shares
Change Vs. Previous Month
-8.15%
Dollar Volume Sold Short
$13.49 million
Short Interest Ratio
1.6 Days to Cover
Last Record Date
June 15, 2025
Outstanding Shares
64,562,000 shares
Float Size
43,370,000 shares
Short Percent of Float
7.79%
Today's Trading Volume
0 shares
Average Trading Volume
2,792,724 shares
Today's Volume Vs. Average
0%
Short Selling Inozyme Pharma?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Inozyme Pharma and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

INZY Short Interest Over Time

INZY Days to Cover Over Time

INZY Percentage of Float Shorted Over Time

Inozyme Pharma Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/15/20253,380,000 shares $13.49 million -8.2%7.8%1.6 $3.99
5/31/20253,680,000 shares $14.54 million -4.2%8.5%1.8 $3.95
5/15/20253,840,000 shares $5.45 million -3.8%8.9%2.1 $1.42
4/30/20253,990,000 shares $4.59 million -9.7%9.1%5.7 $1.15
4/15/20254,420,000 shares $4.41 million +5.0%10.2%7.9 $1.00
3/31/20254,210,000 shares $3.83 million +5.5%9.7%6.1 $0.91
3/15/20253,990,000 shares $3.99 million -9.1%9.2%5.8 $1.00
2/28/20254,390,000 shares $5.27 million +2.1%10.1%6 $1.20
2/15/20254,300,000 shares $5.89 million +17.5%9.9%5.4 $1.37
1/31/20253,660,000 shares $5.27 million -4.9%8.3%4.7 $1.44
1/15/20253,850,000 shares $5.31 million +4.1%8.8%5.5 $1.38
12/31/20243,700,000 shares $10.25 million +11.5%8.4%6.8 $2.77
12/15/20243,320,000 shares $10.06 million -2.6%7.6%7 $3.03
11/30/20243,410,000 shares $9.24 million +3.0%7.8%8.4 $2.71
11/15/20243,310,000 shares $10.34 million +2.5%7.6%11.8 $3.13
10/31/20243,230,000 shares $13.86 million +0.6%7.4%12.3 $4.29
10/15/20243,210,000 shares $17.24 million -12.3%7.5%12.7 $5.37
9/30/20243,660,000 shares $19.14 million -6.9%8.6%14.1 $5.23
9/15/20243,930,000 shares $23.58 million -1.3%9.2%13.5 $6.00
8/31/20243,980,000 shares $22.05 million +0.5%9.4%13.2 $5.54
8/15/20243,960,000 shares $18.57 million -4.8%9.4%12.3 $4.69
7/31/20244,160,000 shares $24.13 million -2.4%9.9%13.3 $5.80
7/15/20244,260,000 shares $23.26 million +3.2%10.2%11.5 $5.46
6/30/20244,130,000 shares $18.42 million +51.3%9.9%8.8 $4.46
6/15/20242,730,000 shares $12.94 million +0.4%6.6%4.8 $4.74
5/31/20242,720,000 shares $13.11 million +1.1%6.5%4.5 $4.82
5/15/20242,690,000 shares $12.56 million -20.7%6.5%4.1 $4.67
4/30/20243,390,000 shares $14.95 million +7.6%8.2%5 $4.41
4/15/20243,150,000 shares $14.84 million +22.1%7.7%4.7 $4.71
3/31/20242,580,000 shares $19.76 million +8.4%6.3%4.2 $7.66
3/15/20242,380,000 shares $14.02 million +2.6%5.8%4.6 $5.89
2/29/20242,320,000 shares $14.76 million -3.3%5.6%4.8 $6.36
2/15/20242,400,000 shares $13.70 million -16.4%5.8%5.4 $5.71
1/31/20242,870,000 shares $15.79 million +4.7%6.8%6.9 $5.50
1/15/20242,740,000 shares $11.54 million -10.8%6.5%6.7 $4.21
12/31/20233,070,000 shares $13.08 million +91.9%7.2%7.6 $4.26
12/15/20231,600,000 shares $6.43 million -28.6%3.8%3.7 $4.02
11/30/20232,240,000 shares $8.62 million -0.4%5.3%4.5 $3.85
11/15/20232,250,000 shares $7.20 million +8.2%5.3%4.2 $3.20
10/31/20232,080,000 shares $6.18 million -15.5%4.7%3.6 $2.97
Are we ignoring the same signal Wall Street ignored in 1929? (Ad)

In 1929, a 20-something broker named Irving Weiss shorted the market before Black Monday and made a fortune. His son Martin digitized those same methods into Weiss Ratings - a system now tracking 22,000 stocks with 1.2 billion daily calculations. That system called the Dot-Com bust, the 2008 crisis, and the 2020 crash. Right now it has issued a Code Red, flagging 10 popular US stocks as must-sells while upgrading 3 under-the-radar companies to an urgent Buy.tc pixel

Watch the free briefing and get the names of the 3 Buy stocks
10/15/20232,460,000 shares $8.35 million +6.5%5.5%3.7 $3.40
9/30/20232,310,000 shares $9.70 million +12.7%5.2%3.3 $4.20
9/15/20232,050,000 shares $8.82 million +21.3%4.6%3 $4.30
8/31/20231,690,000 shares $8.28 million -17.2%4.5%2.6 $4.90
8/15/20232,040,000 shares $9.83 million +11.5%5.4%3.3 $4.82
7/31/20231,830,000 shares $9.33 million +7.7%4.0%2.8 $5.10
7/15/20231,700,000 shares $10.35 million +37.1%4.9%3.1 $6.09
6/30/20231,240,000 shares $6.91 million +248.1%3.5%2 $5.57
6/15/2023356,200 shares $2.07 million +24.9%1.0%0.5 $5.81
5/31/2023285,100 shares $1.71 million -53.0%0.8%0.4 $5.99
5/15/2023606,300 shares $3.93 million No Change1.7%0.7 $6.49
10/31/2022166,500 shares $293.04 thousand -4.8%N/A2.3 $1.76
10/15/2022174,800 shares $457.98 thousand -4.4%N/A2.9 $2.62
9/30/2022182,900 shares $490.17 thousand No ChangeN/A2.4 $2.68
9/15/2022182,900 shares $610.89 thousand -7.6%0.8%1.5 $3.34
8/31/2022197,900 shares $593.70 thousand -25.9%0.9%1.2 $3.00
8/15/2022267,000 shares $1.00 million -18.8%1.2%1.5 $3.76
7/31/2022328,800 shares $1.21 million -26.3%N/A1.7 $3.69
7/15/2022446,200 shares $2.23 million -47.1%N/A1.8 $5.00
6/30/2022842,900 shares $4.02 million -2.5%N/A2.8 $4.77
6/15/2022864,400 shares $4.02 million +0.3%N/A2.8 $4.65
5/31/2022861,600 shares $3.18 million +13.8%N/A3.5 $3.69
5/15/2022757,200 shares $3.20 million -13.6%N/A3.4 $4.23
4/30/2022876,200 shares $3.46 million +118.3%N/A4.2 $3.95
4/15/2022401,300 shares $1.71 million +23.5%1.7%2.3 $4.26
3/31/2022325,000 shares $1.33 million +12.2%N/A3.7 $4.09
3/15/2022289,700 shares $1.17 million -3.9%2.1%4.4 $4.03
2/28/2022301,300 shares $1.74 million +9.7%2.2%4.5 $5.77
2/15/2022274,700 shares $1.95 million +5.2%2.4%4.3 $7.10
1/31/2022261,200 shares $1.74 million +57.7%2.2%4.6 $6.68
1/15/2022165,600 shares $1.12 million +8.2%N/A3.1 $6.74
12/31/2021153,000 shares $1.04 million -13.6%1.3%2.9 $6.82
12/15/2021177,000 shares $987.66 thousand -3.2%1.5%2.8 $5.58
11/30/2021182,800 shares $1.45 million +4.1%1.6%2.4 $7.94
11/15/2021175,600 shares $1.76 million -7.1%1.5%2.1 $10.00
10/29/2021189,100 shares $1.77 million -3.2%1.7%2.3 $9.34
10/15/2021195,400 shares $1.81 million -14.2%1.8%2.2 $9.25
9/30/2021227,800 shares $2.64 million +11.5%2.1%2.5 $11.59
9/15/2021204,300 shares $2.56 million -43.5%1.9%2.4 $12.55
8/31/2021361,500 shares $5.57 million -5.9%3.3%5.2 $15.42
8/13/2021384,100 shares $6.10 million +3.4%3.5%6.3 $15.88
7/30/2021371,400 shares $6.23 million +32.0%3.4%5.9 $16.77
7/15/2021281,300 shares $5.12 million -78.4%2.8%4.8 $18.19
6/30/20211,300,000 shares $22.15 million +26.2%12.7%24.2 $17.04
6/15/20211,030,000 shares $17.64 million +15.4%10.1%21.5 $17.13

INZY Short Interest - Frequently Asked Questions

Short interest is the volume of Inozyme Pharma shares that have been sold short but have not yet been closed out or covered. As of June 15th, traders have sold 3,380,000 shares of INZY short. 7.79% of Inozyme Pharma's shares are currently sold short. Learn More on Inozyme Pharma's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. INZY shares currently have a short interest ratio of 1.6. Learn More on Inozyme Pharma's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.79% of Inozyme Pharma's floating shares are currently sold short.

Inozyme Pharma saw a decline in short interest in the month of June. As of June 15th, there was short interest totaling 3,380,000 shares, a decline of 8.2% from the previous total of 3,680,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Inozyme Pharma currently has issued a total of 64,562,000 shares. Some of Inozyme Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Inozyme Pharma currently has a public float of 43,370,000 shares.

7.79% of Inozyme Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Inozyme Pharma: Hyperliquid Strategies Inc (7.49%), Cronos Group Inc. (1.16%), Savara Inc. (14.38%), Alvotech (0.85%), Kura Oncology, Inc. (19.07%), Schrodinger, Inc. (15.47%), Phathom Pharmaceuticals, Inc. (14.23%), Eton Pharmaceuticals, Inc. (6.77%), Pharming Group N.V. Sponsored ADR (0.01%), Janux Therapeutics, Inc. (13.94%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), Strategy Inc ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks.

Short selling INZY is an investing strategy that aims to generate trading profit from Inozyme Pharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Inozyme Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of INZY, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INZY, twice per month. The most recent reporting period available is June, 15 2025.

Understanding short interest metrics can help you assess how traders are positioning around a stock like INZY:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:INZY) was last updated on 5/30/2026 by MarketBeat.com Staff.
From Our Partners
I paid $5,000 to hear Elon say this
One investor paid $5,000 to be in a private room with Elon Musk in Los Angeles - and what he heard confirmed a...
InvestorPlace | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
This Tech Could Be Bigger Than Apple, Amazon, and Microsoft Combined
A breakthrough technology backed by Elon Musk, Sam Altman, and Nvidia CEO Jensen Huang may hold the answer to ...
Altimetry | Sponsoredtc pixel
Trump Is Eyeing the Biggest Monetary Shift Since Nixon
On August 15, 1971, Nixon ended the Bretton Woods agreement and untethered the dollar from gold. Since that ni...
Americas Gold Company | Sponsoredtc pixel
One page of the SpaceX S-1 will move this stock overnight
When SpaceX files its S-1 in June, the SEC will require full disclosure of operating expenses - including powe...
Behind the Markets | Sponsoredtc pixel
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...
Weiss Ratings | Sponsoredtc pixel